Sunday, February 16, 2020

Text Sunday

19:00 - 22:00: Welcome reception and Speakers' Dinner (By invitation only)

Monday, February 17, 2020

9 - 9:10 am: Welcome Address
  • Stefan Schreiber - Kiel University, Spokesperson of the Clusters of Excellence “Inflammation at Interfaces” and “Precision Medicine in Chronic Inflammation”
09:10 - 10:10 am: Session I: Final colloquium Cluster of Excellence “Inflammation at Interfaces” - Highlights and achievements


  • Stefan Schreiber - Kiel University
  • Enno Hartmann - University of Lübeck


  • Stefan Schreiber - Kiel University
    Microbiota as a target in IBD
  • Stefan Rose-John - Kiel University
    Blockade of IL-6 Trans-Signaling in Inflammation and Cancer
  • Ralf Ludwig - University of Lübeck
    Skin Autoimmunity Research within I@I: Structural Achievements and Reseach Highlights
10:40 - 12:30 pm: Session II: High resolution imaging and innovative technologies – From basic science to clinical use


  • Jörg Köhl - University of Lübeck
  • Jan-Bernd Hövener - Kiel University


  • Robert Huber - University of Lübeck
    Trends and perspectives of advanced optics and optical coherence tomography (OCT) in medicine
  • Friedrich Feuerhake - Hannover Medical School (MHH), Hannover, DE
    Qualitative and quantitative histological evaluation of inflammation
  • Björn Eskofier - Friedrich-Alexander University (FAU), Erlangen, DE
    Wearable Computing and Machine Learning for Digital Health and Precision Medicine
  • Alison Simmons - University of Oxford, Oxford, GB
    Mapping Mucosal Cell Remodeling in Colitis
1:30 - 3:00 pm: Parallel focused workshops
WorkshopChairsImpulse talks
Animal models
(Room: Sao Paolo)
  • Jörg Köhl
  • Oliver Pabst
Oliver Pabst
Going wild - Animal models in the microbiota age
Clinical sequencing
(Room: Los Angeles)
  • Jeanette Erdmann
  • Andre Franke

Dermot McGovern
Next-generation sequencin in the clinic? Some answers, but more questions!

Nutrition in personalized medicine
(Room: Shanghai)
  • Karin Schwarz
Matthias Laudes
Targeted nutrition medicine for metabolic inflammation
Imaging modalities
(Room: Tokio)
  • Jan-Bernd Hövener
Robert Huber
Contribution of advanced imaging to precision medicine
Organoids and stem cells
(Room: Mexico)
  • Christine Klein

Philip Seibler
Organoids and stem cells - models of human disease by design

3:30 - 5:10 pm: Session III: Microbiome as an intervention target – Is it coming?


  • Philip Rosenstiel - Kiel University
  • Hinrich Schulenburg - Kiel University


  • John Baines - Kiel University and Max Planck Institute Plön
    Evolutionary perspectives on gut microbiome intervention
  • Jeroen Raes - Rega Institute, Leuven, BE
    Quantitative microbiome profiling in health and disease
  • Oliver Pabst - RTWH Aachen University, Aachen, DE
    Shaping of antibody responses to the microbiota
  • Petra Bacher - Kiel University
    Human T helper cell responses against intestinal microbiota
6 - 8 pm: Poster session & get-together (with buffet)

Foyer and room Philadelphia (Poster session)

Tuesday, February 18, 2020

8:30 - 10:10 am: Session IV: Genetics and disease behavior – genotype, phenotype, what type?


  • Stephan Weidinger - Kiel University
  • Andre Franke - Kiel University


  • David Ellinghaus - Kiel University
    Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression
  • Dermot McGovern - Cedars-Sinai Medical Center, Los Angeles, US
    Genotype x Phenotype in Crohn’s disease: the path to personalized medicine.
  • Carl Anderson - Sanger Institute, Cambridge, GB
    Using genome sequencing to understand the causes and consequences of IBD
  • Jeanette Erdmann - University of Lübeck
    Is there any news on the genetics of cardiovascular diseases?
10:40 am - 12:20 pm: Session V: Treatment to target – Biomarker, endophenotyping and stratified medicine


  • Diamant Thaçi - University of Lübeck
  • Ulf Müller-Ladner - University of Gießen


  • Gabriela Riemekasten - University of Lübeck
    Autoantibodies as biomarkers and pathogenic drivers for precision medicine in inflammation
  • Philip Helliwell - University of Leeds, Leeds, GB
    Tight control or treat to target in rheumatology
  • James G. Krueger - The Rockefeller University, New York, US
  • Philip Rosenstiel - Kiel University
    Multi-Omics in IBD - are we on track for a more precise medicine?
1:20 - 2:50 pm: Parallel focused workshops
WorkshopChairsImpulse talks

Antibiotic resistance and evolutionary medicine
(Room: Chicago/Dallas)

  • Klaus F. Rabe
  • Hinrich Schulenburg
Hinrich Schulenburg
Charles Darwin meets the antibiotic crisis: can we use evolutionary principles to prevent resistance evolution?
(Room: Los Angeles)
  • David Klatzmann
  • Alexander Scheffold
David Klatzmann
T cell receptor sequencing for predicting efficacy and side effects of immunotherapies
Patient reported outcomes
(Room: Mexico)
  • Philip Helliwell
  • Bimba F. Hoyer

Philip Helliwell
Patient reported outcomes are an essential part of comprehensive patient assessment tools

Johan Burisch
Patient reported outcomes in IBD - not there yet

How to publish in big journals – equal opportunity for everyone?
(Room: Philadelphia)

  • Petra Bacher
  • Jennifer Sargent
  • Philip Rosenstiel
    Prepare for years
  • Petra Bacher
    Be creative
  • David Ellinghaus
    Collaboration counts
  • Stefan Schreiber
    No more animal experiments?
  • Robert Huber
    Technology counts
  • Jennifer Sargent
    Writing up in a smart way
3:20 - 5:10 pm: Session VI: Predictors of response and treatment optimization in PMI


  • Bimba F. Hoyer - Kiel University
  • Christian Sadik - University of Lübeck


  • Diamant Thaçi - University of Lübeck
    Targeted therapy in psoriasis: treatment goals and predictors of response
  • Ursula Grohmann - University of Perugia, Perugia, IT
    Immune checkpoint molecules and personalized medicine in autoimmune diabetes and neuroinflammation
  • Emma Guttman - Mount Sinai Hospital, New York, US
    Biomarkers of treatment response in atopic dermatitis and beyond
  • David Klatzmann - Sorbonne University, Paris, FR
    Optimizing and individualizing IL-2 therapy of autoimmune and inflammatory diseases
5:20 - 5:45 pm: Closing remarks and Poster Awards

Stefan Schreiber - Kiel University

Tuesday: 6:30 - 8:30 pm Sponsored Clinical Sessions (mainly in German)

To the programme of the Sponsored Clinical Sessions (mainly in German)